Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | est un(e) (attribut) | Substance with prostaglandin-endoperoxide synthase inhibitor mechanism of action (substance) | true | Inferred relationship | Some | ||
| Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | est un(e) (attribut) | Non-steroidal anti-inflammatory agent (substance) | true | Inferred relationship | Some | ||
| Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | est un(e) (attribut) | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Has disposition (attribute) | Cyclooxygenase-2 inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ketorolac tromethamine | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Ketorolac (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etodolac (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| népafénac | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Ibuprofen sodium (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Ibuprofen (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Ibuprofen sodium dihydrate (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Ibuprofen lysine (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Dexibuprofen (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Dexketoprofen trometamol (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Dexketoprofen (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| naproxène sodique (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Naproxen (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Fenoprofen (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Fenoprofen calcium | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| alminoprofène | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| étodolac | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Product containing prostaglandin-endoperoxide synthase isoform 2 inhibitor (product) | a pour principe actif (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | 1 |
| Etodolac 200 mg oral capsule | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Product containing precisely etodolac 300 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etodolac 600mg m/r tablet (product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Celecoxib 200 mg oral capsule | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Product containing precisely celecoxib 100 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| célécoxib | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etodolac 500mg m/r tablet (product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etodolac 400mg m/r tablet (product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etodolac 400 mg oral tablet | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etodolac 500 mg oral tablet | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Product containing valdecoxib (medicinal product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Valdecoxib 10 mg oral tablet | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Valdecoxib 20 mg oral tablet | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Nabumetone (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Rofecoxib (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Meloxicam (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Product containing parecoxib (medicinal product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Parecoxib 40mg injection (pdr for recon) (product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Parecoxib 40mg injection (pdr for recon)+diluent (product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| étoricoxib | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etoricoxib 60mg tablet (product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etoricoxib 90mg tablet (product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etoricoxib 120mg tablet (product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etoricoxib 60 mg oral tablet | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etoricoxib 90 mg oral tablet | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etoricoxib 120 mg oral tablet | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Parecoxib 40mg injection (pdr for recon) (product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Parecoxib 40mg injection (pdr for recon)+diluent (product) | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Valdecoxib 40 mg oral tablet | a pour principe actif (attribut) | False | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Celecoxib | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Etoricoxib (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Parecoxib (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Valdecoxib (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Deracoxib (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Firocoxib (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Lumiracoxib (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Nimesulide (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Parecoxib sodium (substance) | est un(e) (attribut) | True | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR